Pseudoginsenoside Rh2 Size:Contact [email protected] for quotation InChi: InChI=1S/C13H11ClN2O2/c1-18-12-8-9(5-6-10(12)14)16-13(17)11-4-2-3-7-15-11/h2-8H

InChi: InChI=1S/C13H11ClN2O2/c1-18-12-8-9(5-6-10(12)14)16-13(17)11-4-2-3-7-15-11/h2-8H

Smiles: ONC(=O)C1C=CC(CN2C3=CC=CC=C3C(=O)N(CCC3C=CC=CC=3)C2=O)=CC=1

Smiles: CCCN1C(=O)C2NC(=NC=2NC1=O)C1C=CC(=CC=1)S(=O)(=O)N1CCN(CC2C=CC(Cl)=CC=2)CC1

with an IC50 of 61 nM and >100-fold selectivity versus the closely related Na-K-2Cl cotransporter 1 (NKCC1) and no activity in a larger panel of GPCRs

org/wiki/Ledipasvir)

Pseudoginsenoside Rh2 Size:Contact [email protected] for quotation InChi: InChI=1S/C13H11ClN2O2/c1-18-12-8-9(5-6-10(12)14)16-13(17)11-4-2-3-7-15-11/h2-8HPseudoginsenoside Rh2, synthesized from Ginsenoside Rh2, possesses anti cancer activitied. Product information CAS Number: 1370264 16 6 Molecular Weight: 622. 87 Formula: C36H62O8 Chemical Name: (2R,3R,4S,5S,6R) 2 {[(1S,3aR,3bR,5aR,7S,9aR,9bR,11R,11aR) 11 hydroxy 1 [(2Z) 6 hydroxy 6 methylhept 2 en 2 yl] 3a,3b,6,6,9a pentamethyl hexadecahydro 1H cyclopenta[a]phenanthren 7 yl]oxy} 6 (hydroxymethyl)oxane 3,4,5 triol Smiles: CC(C)(O)CC C=C(